Cargando…
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
The apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) mutational signature has only recently been detected in a multitude of cancers through next-generation sequencing. In contrast, APOBEC has been a focus of virology research for over a decade. Many lessons learnt regarding...
Autores principales: | Venkatesan, S, Rosenthal, R, Kanu, N, McGranahan, N, Bartek, J, Quezada, S A, Hare, J, Harris, R S, Swanton, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888943/ https://www.ncbi.nlm.nih.gov/pubmed/29324969 http://dx.doi.org/10.1093/annonc/mdy003 |
Ejemplares similares
-
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
por: Kanu, Nnennaya, et al.
Publicado: (2016) -
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
por: McGranahan, Nicholas, et al.
Publicado: (2017) -
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
por: Rosenthal, Rachel, et al.
Publicado: (2016) -
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma
por: Ghorani, E, et al.
Publicado: (2018) -
Analysis of intratumor heterogeneity unravels lung cancer evolution
por: de Bruin, Elza C, et al.
Publicado: (2015)